Levetiracetam Tablet, Film Coated, Extended Release
Product Images NDC 60505-3518

This is a table showing the percentages of Immediate-release Levetiracetam tablets and Fevetiracetam tablets at different dosages (1000 mg/day and 3000 mg/day) compared to Placebo (N=95). The asterisk (*) indicates that the results were statistically significant versus placebo.*

Each tablet contains 1,000 mg of evetiracetam and is manufactured by APOTEX CORP. It comes in a bottle of 60 tablets and should be stored at 20°C to 25°C, protected from moisture. It is a medication that requires a doctor's prescription and once daily dosing is recommended. A medication guide is provided and should be given to the patient by the pharmacist.*

Each tablet of Levetiracetam Extended-Release Tablets contains 500 mg of the active ingredient. The tablets should be stored at a temperature range of 20°C to 25°C, with excursions between 15°C to 30°C permitted. The medication should be protected from moisture and dispensed in a tight, light-resistant container. The typical dosage should be determined by the package insert. This batch contains 60 tablets and has a National Drug Code of 60505-3280-6. The enclosed Medication Guide should be given to the patient by a pharmacist. The manufacturer is Apotex Inc. based in Toronto, Canada and the product is distributed by Apotex Corp. in Florida.*

Each tablet of this medication contains 750 mg of levetiracetam, and should be stored between 20°C to 25°C (68°F o 77°F), with limited deviations permitted from 15°C to 30°C (59°F to 86°F). USP Controlled Room Temperature guidelines should be followed. Protect the tablets from moisture and dispense in a tight, light-resistant container, as per USP guidelines. Refer to the package insert for usual dosage. This bottle contains 60 tablets with NDC 60505-3517-6. This is an extended-release medication meant to be taken once daily. The pharmacist should provide the enclosed medication guide to the patient. The manufacturer is Apotex nc. in Toronto, Ontario. They produced these tablets for Cipla Corp. based in Weston, Florida.*